Evolent Health, Inc. (EVH)
Automate Your Wheel Strategy on EVH
With Tiblio's Option Bot, you can configure your own wheel strategy including EVH - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol EVH
- Rev/Share 20.8016
- Book/Share 8.1127
- PB 1.2943
- Debt/Equity 0.9301
- CurrentRatio 0.9849
- ROIC -0.0127
- MktCap 1232700000.0
- FreeCF/Share -0.0843
- PFCF -126.821
- PE -11.1123
- Debt/Assets 0.3279
- DivYield 0
- ROE -0.1082
- Rating C-
- Score 1
- Recommendation Strong Sell
- P/E Score 1
- DCF Score 1
- P/B Score 4
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | EVH | Needham | -- | Buy | -- | $15 | Jan. 10, 2025 |
| Reiterated | EVH | BTIG Research | -- | Buy | $36 | $29 | Dec. 3, 2024 |
| Initiation | EVH | KeyBanc Capital Markets | -- | Overweight | -- | $35 | Oct. 11, 2024 |
News
Evolent Health (EVH) Stock Jumps 6.9%: Will It Continue to Soar?
Published: June 23, 2025 by: Zacks Investment Research
Sentiment: Positive
Evolent Health (EVH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Read More
Evolent Health (EVH) Reports Q1 Earnings: What Key Metrics Have to Say
Published: May 09, 2025 by: Zacks Investment Research
Sentiment: Positive
Although the revenue and EPS for Evolent Health (EVH) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Read More
Wall Street Analysts Believe Evolent Health (EVH) Could Rally 53.33%: Here's is How to Trade
Published: May 07, 2025 by: Zacks Investment Research
Sentiment: Positive
The average of price targets set by Wall Street analysts indicates a potential upside of 53.3% in Evolent Health (EVH). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Read More
Evolent Health, Inc. (EVH) Q4 2024 Earnings Call Transcript
Published: February 20, 2025 by: Seeking Alpha
Sentiment: Neutral
Evolent Health, Inc. (NYSE:EVH ) Q4 2024 Earnings Conference Call February 20, 2025 5:00 PM ET Company Participants Seth Frank - Vice President, Investor Relations Seth Blackley - Chief Executive Officer John Johnson - Chief Financial Officer Conference Call Participants Matthew Gillmor - KeyBanc Charles Rhyee - TD Cowen Andrea Alfonso - UBS Jailendra Singh - Truist Securities Ryan Daniels - William Blair Jeff Garro – Stephens Anne Samuel - J.P. Morgan Richard Close - Canaccord Genuity Jessica Tassan - Piper Sandler David Larsen - BTIG Daniel Grosslight – Citi Matthew Shea - Needham Operator Welcome to the Evolent Earnings …
Read More
Evolent Health (EVH) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Published: February 20, 2025 by: Zacks Investment Research
Sentiment: Positive
The headline numbers for Evolent Health (EVH) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Read More
Evolent Health (EVH) Reports Q4 Loss, Lags Revenue Estimates
Published: February 20, 2025 by: Zacks Investment Research
Sentiment: Neutral
Evolent Health (EVH) came out with a quarterly loss of $0.02 per share in line with the Zacks Consensus Estimate. This compares to earnings of $0.23 per share a year ago.
Read More
About Evolent Health, Inc. (EVH)
- IPO Date 2015-06-05
- Website https://www.evolenthealth.com
- Industry Medical - Healthcare Information Services
- CEO Mr. Seth Barrie Blackley
- Employees 4500